The DANAMI-3 trials in Denmark enrolled 1,574 STEMI patients without shock, scored on admission for their risk of developing shock in hospital. High-risk patients had more inflammation, with peak C-reactive protein of 72 against 11 mg/L, and larger infarcts. Ten-year mortality from national registration records was 41% against 20%, though most of the excess fell in the first year and age predicted death better.
Why it is interesting: A score built to predict shock in hospital marks larger infarcts, but age explained later deaths.
Cite this item
BibTeX
Free sign-up. A digest of the new papers twice a week, grouped by domain.